Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT [Phase 1, Phase 2]

View source ↗

Summary

Early-phase study using the PET tracer FLUORTRIOPRIDE ([18F]FTP) to evaluate D3 receptor occupancy in cocaine-dependent individuals and healthy volunteers; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUORTRIOPRIDE ([18F]FTP)

Snippet

Sponsor: University of Pennsylvania | Conditions: D3 Dopamine Receptor, Cocaine-dependent | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING